Hueston, James
James Hueston, Senior Associate, Primetime Partners About: James joined the Primetime team in 2022 and was previously an investor at NTTVC, the single LP fund formed in partnership with NTT.…
James Hueston, Senior Associate, Primetime Partners About: James joined the Primetime team in 2022 and was previously an investor at NTTVC, the single LP fund formed in partnership with NTT.…
Denise Saltojanes, MBA, Managing Director, Golden Seeds; Business Coach, SBA T.H.R.I.V.E.; Investor, NuFund Venture Group; Investor, Beacon Angels About: Denise Saltojanes is managing director and deal flow lead with Golden…
Griffin Weber, MD, PhD, Associate Professor of Medicine and Biomedical Informatics at Beth Israel Deaconess Medical Center and Harvard Medical School About: Griffin M Weber, MD, PhD, is an Associate…
Michael Kahana, PhD, Edmund J. and Louise W. Kahn Term Professor of Psychology at theUniversity of Pennsylvania; CEO at nia Therapeutics About: Michael Kahana is the Edmund J. and Louise…
Sudeshna Das, PhD, Director of the Mass General Hospital’s BioMedical Informatics Core and Associate Professor of Neurology at Harvard Medical School, and Data Core Lead for the Massachusetts Alzheimer Disease…
Susann Keohane, PhD, Head of Emerging AI Product Innovation at IBM; a2 Collective External Advisory Panel Member About: Susann Keohane is the IBM Watson Health Innovation Leader for Healthy Aging…
Glenn Cohen, JD, Faculty Director of the Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics at Harvard University Law School; a2 Collective External Advisory Panel Member About: Prof. Cohen…
Brian Anderson, MD, CEO, Coalition for Health AI (CHAI) About: Dr. Brian Anderson is the President and Chief Executive Officer of the Coalition for Health AI (CHAI) where he leads…
Mike Hughes, PhD, Assistant Professor, Computer Science at Tufts University About: Michael C. Hughes ("Mike") is an Assistant Professor of Computer Science at Tufts University, where he does research in…
Alex Zhavoronkov, PhD, Chairman of the Board, Executive and CEO at Insilico Medicine; a2 Collective External Advisory Panel Member About: Alex Zhavoronkov, PhD, is the founder and CEO of Insilico…